Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial
David Kimberlin, Dwight Powell, William Gruber, Pamela Diaz, Ann Arvin, Mary Kumar, Richard Jacobs, Russell Van Dyke, Sandra Burchett, Seng Jaw Soong, Alfred Lakeman, Richard Whitley, C. Laughlin, A. Lakeman, S. J. Soong, D. Kimberlin, S. Stagno, R. Pass, A. Arvin, C. ProberJ. Bradley, S. Spector, L. Corey, G. Demmler, S. Burchett, S. Adler, J. Bale, Y. Bryson, T. Chonmaitree, P. Diaz, J. Gross, W. Gruber, R. Jacobs, H. Keyserling, J. Kinney, A. Kovacs, M. Kumar, S. Laudert, C. Leach, E. Leistikow, R. McKinney, C. Meissner, J. Modlin, D. Powell, M. Rathore, P. Reuman, J. Robinson, W. Vaudry, C. Sander, M. Shelton, M. De Sierra, L. Stanberry, S. Starr, R. Steele, G. Storch, R. Van Dyke, L. Weiner
Dive into the research topics of 'Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial'. Together they form a unique fingerprint.